1 |
Water
| 1件: Water Water | 8件: AVONEX AVONEX; ENBREL; Hiberix; INDOCYANINE GREEN; OMNITROPE; Sterile Water for Injection; Water; WATER FOR INJECTION; | - | - | 21件: 2 2, 5, 6, 13, 17, 22, 35, 46, 53, 57, 63, 65, 67, 78, 84, 96, 97, 206, 226, 278, 299 |
2 |
Carbon dioxide
| 1件: Carbon dioxide Carbon dioxide | 1件: Carbon dioxide Carbon dioxide; | - | - | 2件: 97 97, 158 |
3 |
Acetic acid, glacial
| 1件: Acetic acid Acetic acid | 2件: Acetic acid Acetic acid; Ethanoate; | - | - | 2件: 97 97, 251 |
4 |
Glutamine
| 1件: L-Glutamine L-Glutamine | 2件: Glutamine Glutamine; L-Glutamine; | - | - | 8件: 87 87, 89, 96, 97, 113, 222, 245, 299 |
5 |
Ascorbic acid
| 1件: Ascorbic acid Ascorbic acid | 4件: Acidum ascorbicum Acidum ascorbicum; Ascorbic Acid; Iron; Vitamin C; | - | - | 8件: 10 10, 97, 192, 206, 210, 211, 212, 298 |
6 |
Sucrose
| 1件: Sucrose Sucrose | 1件: Sucrose Sucrose; | - | - | 3件: 62 62, 96, 97 |
7 |
Proline
| 1件: Proline Proline | 1件: Proline Proline; | - | - | 2件: 94 94, 97 |
8 |
Niacinamide
| 1件: Nicotinamide Nicotinamide | 3件: Multivitamin Multivitamin; Niacinamide; NICOTINAMIDE; | - | - | 10件: 2 2, 5, 6, 18, 49, 67, 97, 107, 162, 191 |
9 |
Threonine
| 1件: Threonine Threonine | 1件: Threonine Threonine; | - | - | 2件: 86 86, 97 |
10 |
Maltose
| 1件: Maltose Maltose | 1件: Maltose Maltose; | - | - | 2件: 96 96, 97 |
11 |
Anhydrous lactose
| 1件: Lactose Lactose | 1件: Lactose Lactose; | - | - | 6件: 2 2, 6, 13, 97, 228, 310 |
12 |
Riboflavin
| 1件: Riboflavin Riboflavin | 2件: Riboflavin Riboflavin; Vitamin B2; | - | - | 7件: 38 38, 46, 96, 97, 162, 168, 265 |
13 |
Dextran 1
| 1件: Dextran Dextran | 1件: Dextran Dextran; | - | - | 4件: 2 2, 62, 96, 97 |
14 |
Nitric oxide
| 1件: Nitric Oxide Nitric Oxide | 3件: INOmax INOmax; Nitric Oxide; Nitrosyl; | - | - | 12件: 6 6, 58, 85, 86, 88, 97, 210, 222, 251, 294, 299, 321 |
15 |
Hydrocortisone
| 1件: Hydrocortisone Hydrocortisone | 6件: Cortef Cortef; Cortisol; Cortisone; HYDROCORTISONE; Hydrocortisone cream; Hydrocortisonum; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 10件: 6 6, 41, 46, 53, 75, 78, 81, 83, 97, 299 |
16 |
Salicylic acid
| 1件: Salicylic acid Salicylic acid | 2件: 2-Hydroxybenzoic acid 2-Hydroxybenzoic acid; Salicylic acid; | - | - | 1件: 97 97 |
17 |
Tacrolimus
| 1件: Tacrolimus Tacrolimus | 2件: Prograf Prograf; Tacrolimus; | 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
18 |
Aspirin
| 1件: Acetylsalicylic acid Acetylsalicylic acid | 2件: ACETYLSALICYLIC ACID ACETYLSALICYLIC ACID; Aspirin; | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 14件: 13 13, 22, 46, 49, 51, 58, 64, 86, 97, 113, 158, 210, 231, 251 |
19 |
Gelatin
| 1件: Gelatin Gelatin | 3件: Gelatin Gelatin; Gelatine; Sulfur Colloid; | - | - | 7件: 19 19, 28, 62, 78, 97, 269, 299 |
20 |
Albendazole
| 1件: Albendazole Albendazole | 2件: Albendazole Albendazole; Eskazole; | - | - | 12件: 5 5, 6, 7, 13, 28, 51, 67, 86, 96, 97, 114, 127 |
21 |
Methotrexate
| 1件: Methotrexate Methotrexate | 6件: Methotrexat Methotrexat; METHOTREXATE; METHOTREXATE SODIUM; Metoject; METOTREXATO; Méthotrexate; | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 38件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 |
22 |
Mercaptopurine
| 1件: Mercaptopurine Mercaptopurine | 4件: 6-mercaptopurine 6-mercaptopurine; 6-MP; MERCAPTOPURINE; PURINETHOL; | 1件: HPRT1 HPRT1 💬 | 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | 4件: 65 65, 96, 97, 164 |
23 |
Aminosalicylic acid
| 1件: Aminosalicylic acid Aminosalicylic acid | 2件: 4-Aminosalicylic acid 4-Aminosalicylic acid; AMINOSALICYLIC ACID; | - | - | 2件: 96 96, 97 |
24 |
Hydrocortisone acetate
| 1件: Hydrocortisone acetate Hydrocortisone acetate | 2件: Hydrocortisone Hydrocortisone; HYDROCORTISONE ACETATE; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
25 |
Cyclosporine
| 1件: Cyclosporine Cyclosporine | 10件: Ciclosporin Ciclosporin; CICLOSPORINA; Ciclosporine; Cyclosporin; Cyclosporin A; Cyclosporine; Cyclosporine A; Ikervis; Neoral; Restasis; | 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
26 |
Ciprofloxacin
| 1件: Ciprofloxacin Ciprofloxacin | 2件: Ciprofloxacin Ciprofloxacin; Ciprofloxacin hydrochloride; | - | - | 5件: 2 2, 60, 96, 97, 299 |
27 |
Ergocalciferol
| 1件: Ergocalciferol Ergocalciferol | 3件: Ergocalciferol Ergocalciferol; Vitamin D; Vitamin D2; | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 6件: 46 46, 49, 84, 96, 97, 299 |
28 |
Cholecalciferol
| 1件: Cholecalciferol Cholecalciferol | 5件: Cholecalciferol Cholecalciferol; COLECALCIFEROL; Multivitamin; Vitamin D; Vitamin D3; | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 24件: 6 6, 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 |
29 |
Tetracycline
| 1件: Tetracycline Tetracycline | 2件: Tetracyclin Tetracyclin; Tetracycline; | - | - | 5件: 13 13, 36, 46, 53, 97 |
30 |
Vancomycin
| 1件: Vancomycin Vancomycin | 1件: Vancomycin Vancomycin; | - | - | 8件: 13 13, 46, 70, 94, 96, 97, 296, 299 |
31 |
Allopurinol
| 1件: Allopurinol Allopurinol | 2件: Allopurinol Allopurinol; ALLOPURINOL SODIUM; | 1件: XDH XDH 💬 | 6件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬 | 7件: 6 6, 46, 57, 60, 66, 96, 97 |
32 |
Amoxicillin
| 1件: Amoxicillin Amoxicillin | 4件: Amoxicilina Amoxicilina; AMOXICILLIN; Amoxycillin; Augmentin; | - | - | 9件: 6 6, 19, 46, 63, 84, 96, 97, 222, 299 |
33 |
Azathioprine
| 1件: Azathioprine Azathioprine | 3件: Azathioprine Azathioprine; Azatioprina; Imuran; | - | - | 21件: 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162 |
34 |
Budesonide
| 1件: Budesonide Budesonide | 4件: Budesonide Budesonide; Entocort; Jorveza; Symbicort; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 9件: 66 66, 93, 94, 95, 96, 97, 98, 228, 299 |
35 |
Captopril
| 1件: Captopril Captopril | 1件: Captopril Captopril; | 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 8件: 6 6, 17, 46, 86, 96, 97, 107, 271 |
36 |
Cefuroxime
| 1件: Cefuroxime Cefuroxime | 2件: Cefuroxim Cefuroxim; Cefuroxime; | - | - | 2件: 97 97, 299 |
37 |
Clarithromycin
| 1件: Clarithromycin Clarithromycin | 1件: CLARITHROMYCIN CLARITHROMYCIN; | - | - | 8件: 6 6, 63, 84, 96, 97, 222, 228, 299 |
38 |
Clotrimazole
| 1件: Clotrimazole Clotrimazole | 1件: Clotrimazole Clotrimazole; | - | - | 1件: 97 97 |
39 |
Dexamethasone
| 1件: Dexamethasone Dexamethasone | 5件: Decadron Decadron; Dexametasona; Dexamethasone; DEXAMETHASONE SODIUM PHOSPHATE; Maxidex; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 22件: 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
40 |
Doxycycline
| 1件: Doxycycline Doxycycline | 4件: Doxycyclin Doxycyclin; Doxycycline; DOXYCYCLINE HYCLATE; Doxycycline Tablets; | - | - | 17件: 13 13, 23, 28, 34, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299 |
41 |
Ganciclovir
| 1件: Ganciclovir Ganciclovir | 1件: Ganciclovir Ganciclovir; | - | - | 1件: 97 97 |
42 |
Mesalamine
| 1件: Mesalazine Mesalazine | 10件: 5-Aminosalicylic acid 5-Aminosalicylic acid; 5-ASA; ASACOL; Mesalamine; MESALAZINA; MESALAZINE; Mesalazinum; MEZAVANT; Pentasa; Salofalk; | - | - | 5件: 46 46, 96, 97, 98, 164 |
43 |
Tromethamine
| 1件: Tromethamine Tromethamine | 4件: Tham Tham; Tris; Trometamol; Tromethamine; | - | - | 5件: 51 51, 96, 97, 226, 299 |
44 |
Methylprednisolone
| 1件: Methylprednisolone Methylprednisolone | 4件: Medrol Medrol; Methylprednisolon; Methylprednisolone; Methylprednisolone acetate; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 46件: 2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 |
45 |
Metronidazole
| 1件: Metronidazole Metronidazole | 3件: Flagyl Flagyl; Metronidazol; Metronidazole; | - | - | 7件: 46 46, 51, 63, 94, 96, 97, 291 |
46 |
Niclosamide
| 1件: Niclosamide Niclosamide | 1件: Niclosamide Niclosamide; | - | - | 2件: 46 46, 97 |
47 |
Omeprazole
| 1件: Omeprazole Omeprazole | 4件: Losec Losec; Omeprazol; Omeprazole; OMEPRAZOLE MAGNESIUM; | 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 14件: 6 6, 8, 21, 46, 51, 85, 96, 97, 225, 271, 282, 294, 298, 299 |
48 |
Ondansetron
| 1件: Ondansetron Ondansetron | 1件: Ondansetron Ondansetron; | 5件: HTR3A HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 | 2件: Serotonergic synapse Serotonergic synapse, Taste transduction 💬 | 3件: 6 6, 97, 107 |
49 |
Prednisolone
| 1件: Prednisolone Prednisolone | 3件: Prednisolona Prednisolona; PREDNISOLONE; Prednisolonum; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 42件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
50 |
Prednisone
| 1件: Prednisone Prednisone | 3件: PREDNISONA PREDNISONA; Prednisone; RAYOS; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 45件: 2 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 |
51 |
Pyrimethamine
| 1件: Pyrimethamine Pyrimethamine | 2件: Daraprim Daraprim; PYRIMETHAMINE; | - | - | 12件: 2 2, 4, 6, 13, 19, 46, 51, 63, 65, 96, 97, 265 |
52 |
Pentoxifylline
| 1件: Pentoxifylline Pentoxifylline | 1件: Pentoxifylline Pentoxifylline; | - | - | 12件: 26 26, 56, 84, 86, 93, 96, 97, 113, 220, 222, 296, 298 |
53 |
Caffeine
| 1件: Caffeine Caffeine | 1件: Caffeine Caffeine; | 11件: ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 | 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 |
54 |
Topiramate
| 1件: Topiramate Topiramate | 2件: TOPAMAX TOPAMAX; Topiramate; | 36件: CA2 CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 53件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 6件: 6 6, 97, 140, 144, 156, 193 |
55 |
Midazolam
| 1件: Midazolam Midazolam | 2件: Midazolam Midazolam; Midazolam injection; | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 |
56 |
Fenofibrate
| 1件: Fenofibrate Fenofibrate | 1件: Fenofibrate Fenofibrate; | 1件: PPARA PPARA 💬 | 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 6件: 8 8, 79, 93, 94, 97, 265 |
57 |
Beclomethasone dipropionate
| 1件: Beclomethasone dipropionate Beclomethasone dipropionate | 2件: Beclometasone dipropionate Beclometasone dipropionate; Beclomethasone dipropionate; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 85 85, 97, 98 |
58 |
Ursodiol
| 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 4件: UDCA UDCA; URSODEOXYCHOLIC ACID; Ursodiol; Ursofalk; | 1件: NR1H4 NR1H4 💬 | 1件: Bile secretion Bile secretion 💬 | 14件: 6 6, 8, 20, 46, 67, 84, 93, 94, 95, 96, 97, 234, 296, 299 |
59 |
Aldesleukin
| 1件: Aldesleukin Aldesleukin | 4件: ALDESLEUKIN ALDESLEUKIN; ILT-101; Proleukin; Recombinant human interleukin-2; | 3件: IL2RA IL2RA, IL2RB, IL2RG 💬 | 14件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | 6件: 2 2, 35, 49, 65, 96, 97 |
60 |
Thalidomide
| 1件: Thalidomide Thalidomide | 1件: Thalidomide Thalidomide; | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 20件: 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 |
61 |
Hydroxocobalamin
| 1件: Hydroxocobalamin Hydroxocobalamin | 1件: Hydroxocobalamin Hydroxocobalamin; | - | - | 1件: 97 97 |
62 |
Flupentixol
| 1件: Flupentixol Flupentixol | 1件: Flupentixol Flupentixol; | 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 97 97 |
63 |
Rebamipide
| 1件: Rebamipide Rebamipide | 1件: Rebamipide Rebamipide; | - | - | 4件: 46 46, 53, 97, 271 |
64 |
Fluorescein
| 1件: Fluorescein Fluorescein | 1件: Fluorescein Fluorescein; | - | - | 2件: 22 22, 97 |
65 |
Caffeine hydrate
| 1件: Caffeine Caffeine | 1件: Caffeine Caffeine; | 11件: ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 | 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 |
66 |
Polaprezinc
| 1件: Polaprezinc Polaprezinc | 1件: Polaprezinc Polaprezinc; | - | - | 2件: 96 96, 97 |
67 |
Iron dextran
| 1件: Iron Dextran Iron Dextran | 1件: Iron Dextran Iron Dextran; | - | - | 4件: 62 62, 86, 96, 97 |
68 |
Levocarnitine
| 1件: Levocarnitine Levocarnitine | 4件: Carnitine Carnitine; L-Carnitine; Levocarnitine; Xyzal; | - | - | 11件: 3 3, 5, 13, 53, 58, 86, 96, 97, 265, 298, 316 |
69 |
Lysine
| 1件: Lysine Lysine | 1件: Lysine Lysine; | - | - | 5件: 13 13, 19, 97, 228, 299 |
70 |
Methylene blue
| 1件: Methylene blue Methylene blue | 2件: METHYLENE BLUE METHYLENE BLUE; Methylthioninium chloride; | - | - | 2件: 97 97, 127 |
71 |
Alginic acid
| 1件: Alginic acid Alginic acid | 3件: Algin Algin; Alginate; Alginic acid; | - | - | 4件: 51 51, 53, 97, 299 |
72 |
Maltodextrin
| 1件: Maltodextrin Maltodextrin | 1件: Maltodextrin Maltodextrin; | - | - | 4件: 6 6, 13, 96, 97 |
73 |
Vitamin E
| 1件: Vitamin E Vitamin E | 2件: Alpha-tocopherol Alpha-tocopherol; Vitamin E; | - | - | 12件: 2 2, 6, 13, 20, 46, 49, 90, 96, 97, 206, 299, 317 |
74 |
Terbinafine
| 1件: Terbinafine Terbinafine | 1件: Terbinafine Terbinafine; | - | - | 3件: 96 96, 97, 271 |
75 |
Nitazoxanide
| 1件: Nitazoxanide Nitazoxanide | 1件: Nitazoxanide Nitazoxanide; | - | - | 3件: 46 46, 96, 97 |
76 |
Valganciclovir
| 1件: Valganciclovir Valganciclovir | 1件: Valganciclovir Valganciclovir; | - | - | 4件: 85 85, 97, 299, 331 |
77 |
Rifaximin
| 1件: Rifaximin Rifaximin | 3件: Rifaximin Rifaximin; RIFAXIMINA; Xifaxan; | - | - | 9件: 6 6, 65, 93, 94, 96, 97, 99, 296, 299 |
78 |
Adalimumab
| 1件: Adalimumab Adalimumab | 7件: Adalimumab Adalimumab; Amgevita; Cyltezo; Hulio; Humira; Hyrimoz; Imraldi; | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 17件: 19 19, 37, 40, 41, 46, 56, 84, 96, 97, 107, 160, 164, 222, 226, 269, 270, 271 |
79 |
Infliximab
| 1件: Infliximab Infliximab | 6件: Flixabi Flixabi; Inflectra; Infliximab; REMICADE; Remsima; Zessly; | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 27件: 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 |
80 |
Anakinra
| 1件: Anakinra Anakinra | 2件: Anakinra Anakinra; Kineret; | 2件: IL1R1 IL1R1, IL1R2 💬 | 15件: Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 18件: 2 2, 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 |
81 |
Arginine
| 2件: Arginine Arginine, L-arginine | 6件: Arginina Arginina; Arginine; L-Arg; L-Arginin; L-arginine; R-Gene; | - | - | 20件: 46 46, 46, 58, 65, 67, 67, 78, 78, 96, 96, 97, 97, 98, 98, 113, 113, 210, 251, 299, 299 |
82 |
Rituximab
| 1件: Rituximab Rituximab | 6件: MabThera MabThera; Rituxan; RITUXIMAB; Rixathon; Ruxience; Truxima; | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 48件: 11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
83 |
Basiliximab
| 1件: Basiliximab Basiliximab | 2件: Basiliximab Basiliximab; Simulect; | 1件: IL2RA IL2RA 💬 | 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 6件: 2 2, 50, 66, 97, 222, 228 |
84 |
Abatacept
| 1件: Abatacept Abatacept | 2件: Abatacept Abatacept; ORENCIA; | 2件: CD80 CD80, CD86 💬 | 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 26件: 11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 |
85 |
Lactose
| 1件: Lactose Lactose | 1件: Lactose Lactose; | - | - | 6件: 2 2, 6, 13, 97, 228, 310 |
86 |
Magnesium citrate
| 1件: Magnesium citrate Magnesium citrate | 1件: Magnesium citrate Magnesium citrate; | - | - | 1件: 97 97 |
87 |
Hetastarch
| 1件: Hydroxyethyl Starch Hydroxyethyl Starch | 1件: Hextend Hextend; | - | - | 2件: 96 96, 97 |
88 |
Polyethylene glycol 3350
| 1件: Polyethylene glycol Polyethylene glycol | 4件: Macrogol Macrogol; Macrogol 4000; Polyethylene glycol; Polyethylene Glycol 3350; | - | - | 17件: 6 6, 13, 41, 46, 60, 65, 78, 96, 97, 140, 144, 235, 240, 246, 276, 299, 337 |
89 |
Certolizumab pegol
| 1件: Certolizumab pegol Certolizumab pegol | 2件: CERTOLIZUMAB PEGOL CERTOLIZUMAB PEGOL; Cimzia; | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 8件: 37 37, 46, 49, 96, 97, 107, 226, 271 |
90 |
Daclizumab
| 1件: Daclizumab Daclizumab | 3件: Daclizumab Daclizumab; Zenapax; Zinbryta; | 1件: IL2RA IL2RA 💬 | 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 8件: 13 13, 56, 60, 65, 97, 107, 283, 284 |
91 |
Dextromethorphan
| 1件: Dextromethorphan Dextromethorphan | 4件: Dextromethorphan Dextromethorphan; Dextromethorphan hydrobromide; Dextrometorfano; Nuedexta; | 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 |
92 |
Entecavir
| 1件: Entecavir Entecavir | 1件: Entecavir Entecavir; | - | - | 6件: 46 46, 56, 96, 97, 107, 271 |
93 |
Fosfomycin
| 1件: Fosfomycin Fosfomycin | 1件: Fosfomycin Fosfomycin; | - | - | 3件: 96 96, 97, 222 |
94 |
Lactomin
| 1件: Lactobacillus acidophilus Lactobacillus acidophilus | 4件: Acidophilus Acidophilus; Lacteol; Lactobacillus; Lactobacillus acidophilus; | - | - | 3件: 6 6, 49, 97 |
95 |
Lactobacillus casei
| 1件: Lactobacillus casei Lactobacillus casei | 2件: Fusion Fusion; Lactobacillus casei; | - | - | 10件: 6 6, 11, 13, 46, 49, 69, 70, 97, 271, 296 |
96 |
Golimumab
| 1件: Golimumab Golimumab | 2件: Golimumab Golimumab; SIMPONI; | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 8件: 46 46, 56, 84, 96, 97, 107, 270, 271 |
97 |
Interferon beta-1a
| 1件: Interferon beta-1a Interferon beta-1a | 6件: AVONEX AVONEX; Interferon Beta 1-A; Interferon Beta 1a; Interferon beta-1a; Interferon-beta-1a; REBIF; | 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 4件: 13 13, 26, 96, 97 |
98 |
Iron sucrose
| 1件: Iron sucrose Iron sucrose | 1件: Iron Sucrose Iron Sucrose; | - | - | 3件: 62 62, 96, 97 |
99 |
Lecithin
| 1件: Lecithin Lecithin | 1件: Phosphatidylcholine Phosphatidylcholine; | - | - | 1件: 97 97 |
100 |
Mercaptopurine
| 1件: Mercaptopurine Mercaptopurine | 4件: 6-Mercaptopurine 6-Mercaptopurine; 6-MP; MERCAPTOPURINE; PURINETHOL; | 1件: HPRT1 HPRT1 💬 | 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | 4件: 65 65, 96, 97, 164 |
101 |
Metformin
| 1件: Metformin Metformin | 5件: Metformin Metformin; Metformin HCl; METFORMIN HYDROCHLORIDE; METFORMINA; Metformine; | 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 25件: 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301 |
102 |
Methylprednisolone hemisuccinate
| 1件: Methylprednisolone hemisuccinate Methylprednisolone hemisuccinate | 4件: Methylprednisolone hemisuccinate Methylprednisolone hemisuccinate; Methylprednisolone sodium succinate; Methylprednisolone succinate; SOLU-MEDROL; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 7件: 13 13, 49, 50, 51, 53, 97, 211 |
103 |
Molgramostim
| 1件: Molgramostim Molgramostim | 1件: MOLGRAMOSTIM MOLGRAMOSTIM; | 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 3件: 97 97, 229, 299 |
104 |
Naltrexone
| 1件: Naltrexone Naltrexone | 2件: Naltrexone Naltrexone; Naltrexone Hydrochloride; | 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 13件: 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 |
105 |
Penicillin V
| 1件: Phenoxymethylpenicillin Phenoxymethylpenicillin | 0件: | - | - | 1件: 97 97 |
106 |
Phentermine
| 1件: Phentermine Phentermine | 1件: Phentermine Phentermine; | 5件: MAOA MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Phenylalanine metabolism, Serotonergic synapse, Synaptic vesicle cycle, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 97 97 |
107 |
Plantago seed
| 1件: Plantago seed Plantago seed | 2件: Psyllium Psyllium; Psyllium husk; | - | - | 3件: 6 6, 28, 97 |
108 |
Roflumilast
| 1件: Roflumilast Roflumilast | 1件: Roflumilast Roflumilast; | 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 4件: 84 84, 97, 206, 299 |
109 |
Visilizumab
| 1件: Visilizumab Visilizumab | 1件: Visilizumab Visilizumab; | 3件: CD3D CD3D, CD3E, CD3G 💬 | 11件: Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 2件: 96 96, 97 |
110 |
Ethanol
| 1件: Ethanol Ethanol | 3件: Alcohol Alcohol; Ethanol; PREDNISONE; | - | - | 5件: 58 58, 97, 279, 280, 298 |
111 |
Donkey glue
| 1件: Gelatin Gelatin | 3件: Gelatin Gelatin; Gelatine; Sulfur Colloid; | - | - | 7件: 19 19, 28, 62, 78, 97, 269, 299 |
112 |
Amitriptyline
| 1件: Amitriptyline Amitriptyline | 3件: Amitriptylin Amitriptylin; AMITRIPTYLINE; Amitriptyline hydrochloride; | 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 4件: 78 78, 97, 226, 299 |
113 |
Amoxicillin
| 1件: Amoxicillin Amoxicillin | 4件: Amoxicilina Amoxicilina; AMOXICILLIN; Amoxycillin; Augmentin; | - | - | 9件: 6 6, 19, 46, 63, 84, 96, 97, 222, 299 |
114 |
Atorvastatin
| 1件: Atorvastatin Atorvastatin | 3件: Atorvastatin Atorvastatin; Atorvastatin calcium; Lipitor; | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 19件: 13 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 |
115 |
Balsalazide
| 1件: Balsalazide Balsalazide | 3件: 2-Hydroxybenzoic acid 2-Hydroxybenzoic acid; Balsalazide; Balsalazide Disodium; | - | - | 1件: 97 97 |
116 |
Adomiparin
| 1件: Parnaparin Parnaparin | 2件: Parnaparin Parnaparin; PARNAPARIN SODIUM; | 1件: SERPINC1 SERPINC1 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 97 97 |
117 |
Aminolevulinic acid
| 1件: Aminolevulinic acid Aminolevulinic acid | 4件: 5-ALA 5-ALA; 5-aminolevulinic acid; Aminolevulinic acid; Gliolan; | - | - | 5件: 34 34, 96, 97, 180, 286 |
118 |
Ceftriaxone
| 1件: Ceftriaxone Ceftriaxone | 1件: Ceftriaxone Ceftriaxone; | - | - | 4件: 2 2, 6, 46, 97 |
119 |
Delorazepam
| 1件: Delorazepam Delorazepam | 0件: | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 3件: 6 6, 46, 97 |
120 |
Diosmin
| 1件: Diosmin Diosmin | 1件: Diosmin Diosmin; | - | - | 3件: 46 46, 97, 265 |
121 |
Doxycycline
| 1件: Doxycycline Doxycycline | 4件: Doxycyclin Doxycyclin; Doxycycline; DOXYCYCLINE HYCLATE; Doxycycline Tablets; | - | - | 17件: 13 13, 23, 28, 34, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299 |
122 |
Entecavir
| 1件: Entecavir Entecavir | 1件: Entecavir Entecavir; | - | - | 6件: 46 46, 56, 96, 97, 107, 271 |
123 |
Hyaluronic acid
| 1件: Hyaluronic acid Hyaluronic acid | 2件: Hyaluronate Hyaluronate; Hyaluronic Acid; | - | - | 6件: 46 46, 53, 70, 97, 226, 231 |
124 |
Hydroxychloroquine
| 1件: Hydroxychloroquine Hydroxychloroquine | 3件: HYDROXYCHLOROQUINE HYDROXYCHLOROQUINE; HYDROXYCHLOROQUINE SULFATE; PLAQUENIL; | - | - | 27件: 13 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 |
125 |
Icosapent
| 1件: Icosapent Icosapent | 2件: Eicosapentaenoic acid Eicosapentaenoic acid; Icosapent; | - | - | 11件: 8 8, 46, 48, 49, 96, 97, 113, 296, 297, 301, 338 |
126 |
Inositol
| 1件: Inositol Inositol | 1件: Inositol Inositol; | - | - | 2件: 96 96, 97 |
127 |
Vedolizumab
| 1件: Vedolizumab Vedolizumab | 2件: ENTYVIO ENTYVIO; VEDOLIZUMAB; | 2件: ITGA4 ITGA4, ITGB7 💬 | 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 3件: 94 94, 96, 97 |
128 |
Loperamide
| 1件: Loperamide Loperamide | 2件: Loperamide Loperamide; Loperamide hydrochloride; | 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 13 13, 97 |
129 |
Losartan
| 1件: Losartan Losartan | 3件: Cozaar Cozaar; Losartan; Losartan Potassium; | 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 17件: 17 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
130 |
Melatonin
| 1件: Melatonin Melatonin | 2件: Circadin Circadin; Melatonin; | 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 12件: 6 6, 8, 13, 37, 46, 49, 72, 78, 90, 97, 145, 202 |
131 |
Melitracen
| 1件: Melitracen Melitracen | 1件: Melitracen Melitracen; | - | - | 1件: 97 97 |
132 |
Neomycin
| 1件: Neomycin Neomycin | 1件: Neomycin Neomycin; | - | - | 3件: 96 96, 97, 296 |
133 |
Oseltamivir
| 1件: Oseltamivir Oseltamivir | 1件: Oseltamivir Oseltamivir; | - | - | 2件: 97 97, 299 |
134 |
Rosiglitazone
| 1件: Rosiglitazone Rosiglitazone | 2件: Rosiglitazone Rosiglitazone; Rosiglitazone maleate; | 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 5件: 46 46, 75, 97, 222, 265 |
135 |
Rosuvastatin
| 1件: Rosuvastatin Rosuvastatin | 3件: Crestor Crestor; Rosuvastatin; ROSUVASTATIN CALCIUM; | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 11件: 6 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 |
136 |
Tacrolimus
| 1件: Tacrolimus Tacrolimus | 2件: Prograf Prograf; Tacrolimus; | 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
137 |
Anrukinzumab
| 1件: Anrukinzumab Anrukinzumab | 1件: Anrukinzumab Anrukinzumab; | 1件: IL13 IL13 💬 | 8件: Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | 1件: 97 97 |
138 |
Apremilast
| 1件: Apremilast Apremilast | 2件: Apremilast Apremilast; Otezla; | 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 7件: 46 46, 50, 56, 97, 107, 162, 271 |
139 |
Baminercept
| 1件: Baminercept Baminercept | 2件: Baminercept Baminercept; Baminercept alfa; | 1件: LTB LTB 💬 | 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 4件: 13 13, 46, 53, 97 |
140 |
Ferric carboxymaltose
| 1件: Ferric carboxymaltose Ferric carboxymaltose | 1件: Ferric carboxymaltose Ferric carboxymaltose; | - | - | 4件: 86 86, 96, 97, 299 |
141 |
Ferric sulfate
| 1件: Ferric sulfate Ferric sulfate | 1件: Stasis Stasis; | - | - | 2件: 66 66, 97 |
142 |
Myrrh
| 1件: Myrrh Myrrh | 1件: MYRRH MYRRH; | - | - | 1件: 97 97 |
143 |
Raspberry
| 1件: Raspberry Raspberry | 1件: Raspberry Raspberry; | - | - | 1件: 97 97 |
144 |
German chamomile flower
| 1件: Chamomile Chamomile | 2件: Chamomile Chamomile; MATRICARIA FLOWER; | - | - | 2件: 6 6, 97 |
145 |
Ustekinumab
| 1件: Ustekinumab Ustekinumab | 2件: Stelara Stelara; USTEKINUMAB; | 3件: IL12A IL12A, IL12B, IL23A 💬 | 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 16件: 37 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 |
146 |
Linaclotide
| 1件: Linaclotide Linaclotide | 1件: Linaclotide Linaclotide; | 1件: GUCY2C GUCY2C 💬 | 2件: Metabolic pathways Metabolic pathways, Purine metabolism 💬 | 2件: 6 6, 97 |
147 |
Sotrastaurin
| 1件: Sotrastaurin Sotrastaurin | 1件: Sotrastaurin Sotrastaurin; | 4件: PRKCD PRKCD, PRKCE, PRKCH, PRKCQ 💬 | 29件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagocytosis, GnRH signaling pathway, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 97 97 |
148 |
Remestemcel-L
| 1件: Remestemcel-L Remestemcel-L | 3件: Adult human mesenchymal stem cells Adult human mesenchymal stem cells; Prochymal; Remestemcel-L; | - | - | 3件: 85 85, 96, 97 |
149 |
Etrolizumab
| 1件: Etrolizumab Etrolizumab | 1件: ETROLIZUMAB ETROLIZUMAB; | 1件: ITGB7 ITGB7 💬 | 11件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer 💬 | 2件: 96 96, 97 |
150 |
Tofacitinib
| 1件: Tofacitinib Tofacitinib | 4件: Tasocitinib Tasocitinib; Tofacitinib; Xeljanz; Xeljanz XR; | 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬 | 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 15件: 11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 |
151 |
Telotristat
| 1件: Telotristat Telotristat | 1件: Telotristat Telotristat; | 2件: TPH1 TPH1, TPH2 💬 | 4件: Folate biosynthesis Folate biosynthesis, Metabolic pathways, Serotonergic synapse, Tryptophan metabolism 💬 | 1件: 97 97 |
152 |
Tralokinumab
| 1件: Tralokinumab Tralokinumab | 1件: Tralokinumab Tralokinumab; | 1件: IL13 IL13 💬 | 8件: Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | 2件: 85 85, 97 |
153 |
Nivolumab
| 1件: Nivolumab Nivolumab | 1件: Nivolumab Nivolumab; | 1件: PDCD1 PDCD1 💬 | 3件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | 12件: 13 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 |
154 |
Dupilumab
| 1件: Dupilumab Dupilumab | 2件: Dupilumab Dupilumab; Dupixent; | 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 5件: 51 51, 97, 98, 160, 162 |
155 |
Guselkumab
| 1件: Guselkumab Guselkumab | 2件: Guselkumab Guselkumab; TREMFYA; | 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 5件: 37 37, 41, 51, 96, 97 |
156 |
Bezlotoxumab
| 1件: Bezlotoxumab Bezlotoxumab | 1件: Bezlotoxumab Bezlotoxumab; | - | - | 2件: 96 96, 97 |
157 |
Empagliflozin
| 1件: Empagliflozin Empagliflozin | 2件: Empagliflozin Empagliflozin; Jardiance; | 1件: SLC5A2 SLC5A2 💬 | - | 6件: 58 58, 65, 67, 72, 97, 257 |
158 |
Catridecacog
| 1件: Catridecacog Catridecacog | 1件: Catridecacog Catridecacog; | - | - | 2件: 97 97, 288 |
159 |
Methylthioninium chloride hydrate
| 1件: Methylene blue Methylene blue | 2件: METHYLENE BLUE METHYLENE BLUE; Methylthioninium chloride; | - | - | 2件: 97 97, 127 |
160 |
Abrilumab
| 1件: Abrilumab Abrilumab | 1件: Abrilumab Abrilumab; | 2件: ITGA4 ITGA4, ITGB7 💬 | 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 2件: 96 96, 97 |
161 |
Filgotinib
| 1件: Filgotinib Filgotinib | 2件: FILGOTINIB FILGOTINIB; Jyseleca; | 1件: JAK1 JAK1 💬 | 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 6件: 46 46, 53, 96, 97, 222, 271 |
162 |
Amiselimod
| 1件: Amiselimod Amiselimod | 1件: Amiselimod Amiselimod; | 5件: S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 97 97 |
163 |
Brazikumab
| 1件: Brazikumab Brazikumab | 1件: BRAZIKUMAB BRAZIKUMAB; | 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 |
164 |
Cannabidiol
| 1件: Cannabidiol Cannabidiol | 4件: CANNABIDIOL CANNABIDIOL; Epidiolex; Epidyolex; SATIVEX; | 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 20件: 2 2, 6, 8, 13, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 |
165 |
Etrasimod
| 1件: Etrasimod Etrasimod | 1件: Etrasimod Etrasimod; | 5件: S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 96 96, 97, 98 |
166 |
Itacitinib
| 1件: Itacitinib Itacitinib | 1件: ITACITINIB ITACITINIB; | 1件: JAK1 JAK1 💬 | 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 4件: 46 46, 51, 97, 228 |
167 |
Mongersen
| 1件: Mongersen Mongersen | 1件: Mongersen Mongersen; | 1件: SMAD7 SMAD7 💬 | 2件: Hippo signaling pathway Hippo signaling pathway, TGF-beta signaling pathway 💬 | 2件: 96 96, 97 |
168 |
Ozanimod
| 1件: Ozanimod Ozanimod | 2件: Ozanimod Ozanimod; Zeposia; | 5件: S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 13 13, 96, 97 |
169 |
Upadacitinib
| 1件: Upadacitinib Upadacitinib | 2件: Rinvoq Rinvoq; Upadacitinib; | 1件: JAK1 JAK1 💬 | 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 8件: 40 40, 41, 46, 49, 96, 97, 107, 271 |
170 |
Vamorolone
| 1件: Vamorolone Vamorolone | 1件: VAMOROLONE VAMOROLONE; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 97 97, 113 |
171 |
Risankizumab
| 1件: Risankizumab Risankizumab | 1件: Risankizumab Risankizumab; | 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 4件: 37 37, 96, 97, 271 |
172 |
Mirikizumab
| 1件: Mirikizumab Mirikizumab | 1件: MIRIKIZUMAB MIRIKIZUMAB; | 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 3件: 37 37, 96, 97 |
173 |
Bimekizumab
| 1件: Bimekizumab Bimekizumab | 1件: BIMEKIZUMAB BIMEKIZUMAB; | 2件: IL17A IL17A, IL17F 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 3件: 46 46, 97, 271 |
174 |
Ravagalimab
| 1件: Ravagalimab Ravagalimab | 1件: RAVAGALIMAB RAVAGALIMAB; | 1件: CD40 CD40 💬 | 17件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis 💬 | 2件: 53 53, 97 |
175 |
Efavaleukin alfa
| 1件: Efavaleukin alfa Efavaleukin alfa | 1件: EFAVALEUKIN ALFA EFAVALEUKIN ALFA; | - | - | 2件: 49 49, 97 |
176 |
Deucravacitinib
| 1件: Deucravacitinib Deucravacitinib | 1件: Deucravacitinib Deucravacitinib; | 1件: TYK2 TYK2 💬 | 16件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis 💬 | 3件: 49 49, 96, 97 |
177 |
Efmarodocokin alfa
| 1件: Efmarodocokin alfa Efmarodocokin alfa | 2件: Efmarodocokin alfa Efmarodocokin alfa; IL-22Fc; | 1件: IL22 IL22 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬 | 2件: 96 96, 97 |
178 |
Spesolimab
| 1件: Spesolimab Spesolimab | 1件: SPESOLIMAB SPESOLIMAB; | 1件: IL1RL2 IL1RL2 💬 | 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | 3件: 37 37, 96, 97 |
179 |
Cobitolimod
| 1件: Cobitolimod Cobitolimod | 1件: COBITOLIMOD COBITOLIMOD; | 1件: TLR9 TLR9 💬 | 9件: African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 97 97 |